AAI 2022 | Booth #607
May 6–10, 2022
Advancing cancer and immunotherapy research with immunosequencing
The American Association of Immunologists (AAI) Annual Meeting is the largest annual immunology event worldwide, where leading researchers come to learn the latest in their field. With major lectures from some of the world’s most prominent immunologists, and podium and poster presentations of abstracts, IMMUNOLOGY2022™ will feature cutting-edge developments from scientists at every career stage.
Adaptive is excited to be hosting a workshop during the event, where we will be highlighting the exciting research applications utilizing the immunoSEQ Assay in the analyses of vaccines and viral infections. If you are attending AAI in-person, we hope you’ll stop by booth #607 and connect.
Research applications utilizing the immunoSEQ Assay in vaccine and viral infection studies
Saturday, May 7 | 11:15am-12:00pm
Exhibitor Workshop Theater Room #1, Exhibit Hall, Oregon Convention Center
Join us for an overview of immunoSEQ Technology where we will present data generated to:
- Identify and track vaccine-specific and virus-specific T cells circulating in blood longitudinally
- Distinguish T-cell receptors (TCRs) specific for Zika and Dengue viruses
- Determine the impact of immunotherapy on tumor-infiltrating T cells
He will also discuss bioinformatic analyses of TCR sequences to infer viral infection status.
Kaylani Merrill, MS, MBA
Senior Research Account Manager
Richard J. DiPaolo, Ph.D.
Professor and Interim Chair
Department of Molecular Microbiology & Immunology, Saint Louis University School of Medicine
Have Questions? Need to speak with someone?
Learn how immunoSEQ® T-MAP™ COVID can help uncover the T-cell immune response in COVID-19.Learn More
Looking for more information? Help with experimental design or technical support? Interested in speaking to someone?Contact Us
Your one stop shop for webinars, blogs, events, technical documents, videos, & more. Create a free account today!Learn More